We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Glanbia Plc | LSE:GLB | London | Ordinary Share | IE0000669501 | ORD EUR0.06 (CDI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 17.65 | 16.86 | 18.44 | 3,960 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 5.43B | 344.5M | 1.2652 | 13.95 | 4.81B |
TIDMGLB
RNS Number : 0483P
Glanbia PLC
23 May 2018
Glanbia plc holds Capital Markets Day and sets out five year ambition
23 May 2018, Glanbia plc ("Glanbia", the "Group" or the "PLC") is holding a Capital Markets Day ("CMD") today at its Downers Grove, Illinois, USA innovation center. The CMD will run from 8am local time (2pm BST) to 12 noon local time (6pm BST). During the CMD, Glanbia will reiterate its 2018 full year guidance and outline its five year financial ambition. The CMD will be webcast, details of which are provided below.
Commenting today, Siobhán Talbot, Group Managing Director of Glanbia said:
"I'm very pleased to host our 2018 Capital Markets Day at our innovation Center in Downers Grove, Illinois. Over the course of the event, my colleagues and I will outline our ambition to grow total Group revenue from EUR3.6 billion, pro forma(1) , in 2017 to over EUR5.0 billion by 2022. Glanbia is today a focused Group with market leading platforms in performance nutrition, value added nutritional solutions and dairy ingredients. We are well positioned to capture growth from global consumer nutrition trends related to health & wellness, active lifestyles and clean ingredients."
Medium term ambition
Glanbia Group, with its three platforms of Glanbia Performance Nutrition, Glanbia Nutritionals and Strategic Joint Ventures is positioned to deliver long term sustainable growth. This will be enabled by organic growth and selective M&A. The Group's balance sheet is strong and Glanbia has the capacity to fund future growth opportunities.
The five year ambition which will be outlined at the CMD is as follows:
Key performance indicator Metric ---------------------------------------------------- --------------- Total Group revenue (including Glanbia share of Joint Ventures) by 2022 EUR5.0 billion ---------------------------------------------------- --------------- 5 year average adjusted earnings per share growth, constant currency, 2018 to 2022 5% to 10% ---------------------------------------------------- --------------- Annual return on capital employed 10% to 13% ---------------------------------------------------- --------------- Annual operating cash conversion Greater than 80% ---------------------------------------------------- ---------------
CMD Agenda - 23 May 2018
Speaker CST BST --------------------------------------- ------------------- ----------------- Siobhán Talbot, Glanbia 8:00am to 8.45am 2.00pm to 2.45pm Group Managing Director, Introduction and strategy --------------------------------------- ------------------- ----------------- Brian Phelan, CEO, Glanbia 8.45am to 9.30am 2.45pm to 3.30pm Nutritionals --------------------------------------- ------------------- ----------------- Break 10 minutes 10 minutes --------------------------------------- ------------------- ----------------- Hugh McGuire, CEO Glanbia Performance 9.40am to 10.25am 3.40pm to 4.25pm Nutrition --------------------------------------- ------------------- ----------------- Mark Garvey, CFO, Glanbia 10.25am to 11.10am 4.25pm to 5.10pm --------------------------------------- ------------------- ----------------- Questions and answers with 11.10am to 11.50am 5.10pm to 5.50pm all speakers --------------------------------------- ------------------- -----------------
Webcast
Details on how to view the webcast can be found at the following link: https://www.glanbia.com/investors/investor-day-2018
Full year 2018 reiteration of guidance
Glanbia reiterates its previously stated guidance that on a pro-forma(2) basis adjusted earnings per share for the continuing Group is expected to grow between 5% - 8%, constant currency, for full year 2018. Earnings growth is expected to be delivered in the second half of 2018.
1 Total Group Revenue includes wholly owned revenue and Glanbia's share of revenue from Joint Ventures. The 2017 pro-forma total Group Revenue number includes the full year effect of an acquisition made by Joint Ventures during the year.
2 Pro-forma adjusted Earnings Per Share of the continuing Group, constant currency. This eliminates the contribution of discontinued operations from prior year comparatives. Discontinued operations relates to assets which were sold on 2 July 2017.
ENDS
Cautionary statement
This announcement contains forward-looking statements. These statements have been made by the Directors in good faith based on the information available to them up to the time of their approval of this announcement. Due to the inherent uncertainties, including both economic and business risk factors underlying such forward looking information, actual results may differ materially from those expressed or implied by these forward-looking statements. The Directors undertake no obligation to update any forward-looking statements contained in this announcement, whether as a result of new information, future events, or otherwise.
For further information contact
Glanbia plc +353 56 777 2200
Mark Garvey, Group Finance Director
Liam Hennigan, Head of Investor Relations: +353 86 046 8375
Martha Kavanagh, Head of Media Relations: +353 87 646 2006
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
MSCPGUQCAUPRGUW
(END) Dow Jones Newswires
May 23, 2018 07:00 ET (11:00 GMT)
1 Year Glanbia Chart |
1 Month Glanbia Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions